Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Financial results for quarter and half year ended September 30, 2026

Date: November 10, 2026 The Department of Corporate Services, BSE Limited, Mumbai BSE Script Code: 540359 Dear Sir / Madam, SUB: INTIMATION OF BOARD MEETING FOR APPROVAL OF FINANCIAL RESULTS (UNAUDITED) FOR THE QUARTER AND HALF YEAR ENDED ON SEPTEMBER 30, 2026. Pursuant to Regulation 29 of the SEBI Listing Regulations, 2015, we hereby inform the Stock Exchange that the Meeting of Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026 inter alia to transact the following matters: 1. To consider and approve approval of unaudited financial results for the quarter and half year ended on September 30, 2026. 2. Shifting of the Registered office of the Company. Further, as communicated earlier, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and as per the Company's Code to Regulate, Monitor and Report Trading by Insiders, the trading window for dealing in the securities of the Company has been closed up to forty-eight hours after the announcement of the financial results for the quarter and half year ended on September 30, 2026. Please take the same on your records. Thanking you. Yours faithfully, For, PARMAX PHARMA LIMITED Umang Gosalia Managing Director DIN: 05153830